| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_62bf2c8e3be7f282db6e658eb393bed1 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K2300-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-16
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P25-28
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0014
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-724 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-724
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
| filingDate |
2014-12-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b16e4821fdbb080f47dd42cafaae1e5a
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d580246625e416a137a78a99f95a582
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2ea7a59c2587aa4c7dfc66024e73675b
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_239d0b04ee4a622617c67585508b7a81
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_e930626b28b22123d44e1b091a5398fc |
| publicationDate |
2021-12-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20210158867-A |
| titleOfInvention |
Compositions based on methyl cyclodextrins for the treatment and/or prevention of diseases by increasing the hdl cholesterol level |
| abstract |
The present invention provides a pharmaceutical composition comprising at least one methyl cyclodextrin having a molar substitution degree (MS) of 0.05 to 1.5 in the treatment and/or prevention of a disease that can be treated and/or prevented by increasing the HDL cholesterol level. It relates to novel uses of the composition. The present invention also relates to the use of said pharmaceutical composition in the treatment and/or prophylaxis of atherosclerosis or complications associated with atheroma, and/or diseases of the central nervous system. The pharmaceutical compositions of the present invention may also be used to stimulate the reduction of circulating fatty acid and triglyceride levels and the reduction or prevention of atheromatous plaques. |
| priorityDate |
2013-12-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |